Two weeks after the United States declared support for a temporary waiver on intellectual property protections for COVID-19 vaccines, the EU is still struggling to agree on a joint position. Germany where BioNTech – one of the leading mRNA vaccine developers – is headquartered is leading opposition against the so-called TRIPS Waiver. The fact that many EU member states are reluctant to consider this instrument may prolong the COVID-19 pandemic.
An unexpected ally
The TRIPS Waiver initially put forward by India and South Africa would allow WTO members to temporarily suspend intellectual property protections to make diagnostics, therapies, and vaccines more widely available and more affordable. TRIPS stands for the Agreement on Trade-Related Aspects of Intellectual Property Rights, which is a core treaty of the World Trade Organization. Wikimedia Deutschland supports the TRIPS Waiver.Read More »A little less conversation, a little more action, please: The EU and the TRIPS Waiver